These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 10777424

  • 1. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA.
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA, Wang X, Payne WG, Ko F, Robson MC.
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [Abstract] [Full Text] [Related]

  • 3. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
    Rayan GM, Tomasek JJ.
    Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
    [Abstract] [Full Text] [Related]

  • 4. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B, Grobbelaar AO, Wilson GD, Smith PJ, Sanders R, McGrouther DA.
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [Abstract] [Full Text] [Related]

  • 5. 5-fluorouracil selectively inhibits collagen synthesis.
    Bulstrode NW, Mudera V, McGrouther DA, Grobbelaar AO, Cambrey AD.
    Plast Reconstr Surg; 2005 Jul; 116(1):209-21; discussion 222-3. PubMed ID: 15988270
    [Abstract] [Full Text] [Related]

  • 6. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J, Rayan GM.
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [Abstract] [Full Text] [Related]

  • 7. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C, Liu F, Gallo PH, Baratz ME, Kathju S, Satish L.
    BMC Musculoskelet Disord; 2016 Nov 11; 17(1):469. PubMed ID: 27835939
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS, Midwood K, Davidson D, Eastwood M, Nanchahal J.
    J Cell Physiol; 2010 Sep 11; 224(3):681-90. PubMed ID: 20432463
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
    Zhou C, Zeldin Y, Baratz ME, Kathju S, Satish L.
    BMC Musculoskelet Disord; 2019 Mar 30; 20(1):135. PubMed ID: 30927912
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
    Bisson MA, Mudera V, McGrouther DA, Grobbelaar AO.
    Plast Reconstr Surg; 2004 Feb 30; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
    [Abstract] [Full Text] [Related]

  • 16. An insight into Dupuytren's contracture.
    Murrell GA.
    Ann R Coll Surg Engl; 1992 May 30; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.